Case of the week 19/2019


Use of CytoSorb in the setting of Hong Kong influenza (А/H3N2), toxic hepatitis and multiple organ failure in a pediatric patient
K.V. Serednyakov1, R.Z. Akhmetshin2; R.N. Bogdanov2 1FMBA Children Infections Scientific Research Center, St. Petersburg, Russia 2Republican Children Clinical Hospital, Ufa, Russia

This case reports on a 2-year-old girl who was admitted to the Infections Clinical Hospital with sym- ptoms of central nervous system (CNS) depression.


The Therapy

An extracorporeal blood purification therapy to reduce excessive inflammation mediators

The Fields of Application

Treat septic shock & severe sepsis on ICU, prevent SIRS in cardiac surgery patients

The Studies

Current multi- and monocentric study projects in Europe and US, an international registry, case series

The Adsorber

A cutting edge bead technology turns CytoSorb into the only specifically approved extracorporeal cytokine adsorber

CytoSorb registry

Become part of the International CytoSorb registry!

For the first time treatment data, courses of treatment and results of a new treatment are systematically recorded according to highest scientific standards.